CLINICAL_TRIALS
ClinicalTrials.gov record update
Therapeutic Efficacy of Wilms' Tumor Gene (WT1) MRNA-electroporated Autologous Dendritic Cell Vaccination in Patients with Solid Tumors: a Phase I/feasibility Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01291420
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:04.013305+00:00
- Published At
- 2024-12-09T00:00:00+00:00
- Record Updated At
- 2024-12-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Glioblastoma", "Renal Cell Carcinoma", "Sarcomas", "Breast Cancers", "Malignant Mesothelioma", "Colorectal Tumors"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-09"- protocolSection.identificationModule.nctId
"NCT01291420"- protocolSection.identificationModule.officialTitle
"Therapeutic Efficacy of Wilms\u0027 Tumor Gene (WT1) MRNA-electroporated Autologous Dendritic Cell Vaccination in Patients with Solid Tumors: a Phase I/feasibility Study"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.